Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 27,637 shares at $0.13 ($4K) on 2016-08-24, disclosed to the SEC on 2016-08-25.
Open-market purchase of $4k LXRP by CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 3,000 | $375 | 10.6% |
| 2 | $0.12 | 14,637 | $2K | 51.2% |
| 3 | $0.13 | 5,000 | $655 | 18.5% |
| 4 | $0.14 | 5,000 | $700 | 19.7% |
| Total | $0.13 avg | 27,637 | $4K | 100% |
| Filing → |
| LXRP | BUY | 2016-07-15 | $7K | — | Filing → |
| LXRP | BUY | 2016-01-12 | $4K | — | Filing → |